SEC Form SC 13D/A filed by GreenLight Biosciences Holdings PBC (Amendment)

$GRNA
Biotechnology: Pharmaceutical Preparations
Health Care
Get the next $GRNA alert in real time by email
SC 13D/A 1 sc13da_072823.htm SC 13D/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934 (Amendment No. 1)

GreenLight Biosciences Holdings, PBC
(Name of Issuer)

 

Common Stock, par value $0.0001 per share
(Title of Class of Securities)

 

39536G 105
(CUSIP Number)

 

Rafael Urquia II, Esq.

c/o Fox Horan & Camerini LLP

885 Third Avenue, 17th Floor

New York, NY 10022

(212) 480-4800

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

July 24, 2023
(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box .

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

SCHEDULE 13D

 

CUSIP No. 39536G 105

 

1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Boscolo Intervest Limited
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) 

(b)  (1)

3 SEC USE ONLY
 
4 SOURCE OF FUNDS (See Instructions)
WC
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
Not Applicable
6 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH
7 SOLE VOTING POWER

 

 

8 SHARED VOTING POWER

0

 

9 SOLE DISPOSITIVE POWER

 

 

 

10 SHARED DISPOSITIVE POWER

0

 

 

 

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14 TYPE OF REPORTING PERSON (See Instructions)
CO
       
(1)Chelt Trading Limited is the sole shareholder of Boscolo Intervest Limited. The Highview Trust, a grantor trust, is the sole shareholder of Chelt Trading Limited. Jaime Javier Montealegre Lacayo is the settlor, trustee, and sole beneficiary of The Highview Trust, and as such, possesses the ultimate voting and dispositive power over securities held by Boscolo Intervest Limited.

 

 

Page 2

SCHEDULE 13D

 

CUSIP No. 39536G 105

 

1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Chelt Trading Limited
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) 

(b) ☐ (1)

3 SEC USE ONLY
 
4 SOURCE OF FUNDS (See Instructions)
WC
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
Not Applicable
6 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH
7 SOLE VOTING POWER

 

 

8 SHARED VOTING POWER

0

 

9 SOLE DISPOSITIVE POWER

 

 

 

10 SHARED DISPOSITIVE POWER

0

 

 

 

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14 TYPE OF REPORTING PERSON (See Instructions)
CO
       

(1)Chelt Trading Limited is the sole shareholder of Boscolo Intervest Limited. The Highview Trust, a grantor trust, is the sole shareholder of Chelt Trading Limited. Jaime Javier Montealegre Lacayo is the settlor, trustee, and sole beneficiary of The Highview Trust, and as such, possesses the ultimate voting and dispositive power over securities held by Boscolo Intervest Limited.

 

 

Page 3

SCHEDULE 13D

 

CUSIP No. 39536G 105

 

1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
The Highview Trust
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) 

(b)  (1)

3 SEC USE ONLY
 
4 SOURCE OF FUNDS (See Instructions)
OO
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
Not Applicable
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH
7 SOLE VOTING POWER

 

 

8 SHARED VOTING POWER

 

9 SOLE DISPOSITIVE POWER

 

 

 

10 SHARED DISPOSITIVE POWER

 

 

 

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14 TYPE OF REPORTING PERSON (See Instructions)
OO
       

(1)Chelt Trading Limited is the sole shareholder of Boscolo Intervest Limited. The Highview Trust, a grantor trust, is the sole shareholder of Chelt Trading Limited. Jaime Javier Montealegre Lacayo is the settlor, trustee, and sole beneficiary of The Highview Trust, and as such, possesses the ultimate voting and dispositive power over securities held by Boscolo Intervest Limited.

 

 

Page 4

SCHEDULE 13D

 

CUSIP No. 39536G 105

 

1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Jaime Javier Montealegre Lacayo
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) 

(b)  (1)

3 SEC USE ONLY
 
4 SOURCE OF FUNDS (See Instructions)
PF
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
Not Applicable
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Nicaragua
NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH
7 SOLE VOTING POWER

 

 

8 SHARED VOTING POWER

 

9 SOLE DISPOSITIVE POWER

 

 

 

10 SHARED DISPOSITIVE POWER

 

 

 

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
14 TYPE OF REPORTING PERSON (See Instructions)
IN
       

(1)Chelt Trading Limited is the sole shareholder of Boscolo Intervest Limited. The Highview Trust, a grantor trust, is the sole shareholder of Chelt Trading Limited. Jaime Javier Montealegre Lacayo is the settlor, trustee, and sole beneficiary of The Highview Trust, and as such, possesses the ultimate voting and dispositive power over securities held by Boscolo Intervest Limited.

 

 

Page 5

 

Explanatory Note:

 

This Amendment No. 1 (the “Amendment”) amends and supplements the Schedule 13D filed by Boscolo Intervest Limited, Chelt Trading Limited, The Highview Trust and Jaime Javier Montealegre Lacayo (collectively, the “Reporting Persons”) on June 9, 2023 (the “Original Schedule 13D” and, as amended and supplemented by this Amendment, the “Schedule 13D”) with respect to shares of common stock, par value $0.0001 per share (the “Common Stock”), of Greenlight Biosciences Holdings, PBC, a Delaware public benefit corporation (the “Issuer”). Capitalized terms used herein and not otherwise defined in this Amendment shall have the meaning ascribed to them in the Original Schedule 13D.

 

Item 4.Purpose of Transaction

 

Item 4 of the Statement is hereby amended and supplemented as follows:

 

On July 24, 2023, pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the “Closing”).

 

Immediately prior to the Closing, pursuant to the Merger Agreement and a Contribution and Exchange Agreement made as of May 29, 2023, by and between Boscolo Intervest Limited and Parent, Boscolo Intervest Limited contributed all of its shares of Common Stock of Issuer to Parent in exchange for shares of Series A-2 Preferred Stock of Parent.

 

Item 5.Interest in Securities of the Issuer

 

Item 5 of the Original Schedule 13D is hereby amended and restated in its entirety as follows:

 

(a)-(b)    This Amendment is being filed on behalf of the Reporting Persons to report that, as of the Closing, the Reporting Persons do not beneficially own any shares of Common Stock of Issuer.

 

(c)          Except as described in Item 4, during the past 60 days, the Reporting Persons have not effected any transactions with respect to the Common Stock of Issuer.

 

(d)          No person other than the Reporting Persons are known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Common Stock of Issuer held by the Reporting Persons.

 

(e)          July 24, 2023.

 

 

Page 6

Signatures

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: July 28, 2023
  Boscolo Intervest Limited
   
  By: /s/ Rafael Urquia II
    Rafael Urquia II
    Its: Director / Secretary
   
   
  Chelt Trading Limited
   
  By:  /s/ Rafael Urquia II
    Rafael Urquia II
    Its: Director / Secretary
   
   
  The Highview Trust
   
  By: /s/ Jaime Javier Montealegre Lacayo
    Jaime Javier Montealegre Lacayo
    Its: Trustee
   
   
  Jaime Javier Montealegre Lacayo
   
  By: /s/ Jaime Javier Montealegre Lacayo
  Name: Jaime Javier Montealegre Lacayo
   

 

 

 

 

 

Get the next $GRNA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GRNA

DatePrice TargetRatingAnalyst
12/8/2022$4.00Buy
Canaccord Genuity
10/14/2022$5.50Outperform
Credit Suisse
More analyst ratings

$GRNA
Press Releases

Fastest customizable press release news feed in the world

See more
  • GreenLight Announces Completion of Merger with Fall Line Endurance Fund

    LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced the closing of its previously announced merger with SW MergerCo, Inc. ("Merger Sub") and SW ParentCo, Inc. ("Parent"), pursuant to which Merger Sub merged with and into GreenLight with GreenLight surviving as a wholly-owned subsidiary of Parent (the "Merger"). Following the completion of the Merger, shares of GreenLight common stock, par value $0.0001 per share, and GreenLight warrants ceased trading on the NASDAQ Global Market (the "NASDAQ") before market open on July 24, 2023, and will no longer be listed for trading on the NASDAQ. Each r

    $GRNA
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares

    LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. ("Merger Sub") and SW ParentCo, Inc ("Parent"). Following the completion of the Merger, shares of GreenLight common stock are expected to cease trading on the NASDAQ Global Market ("NASDAQ") after market close on July 20, 2023, and will no longer be listed for trading on the NASDAQ. Merger Sub's tender offer (the "Offer") to purchase any and all outstanding shares of GreenLight's common stock (other than shares of GreenLight common stock (

    $GRNA
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • Lifshitz Law PLLC Announces Investigations of GRNA, AAIC, EMBK, and REUN

    NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of GRNA to a group of buyers led by Fall Line Capital, LLC for $0.30 per share in cash. If you are a GRNA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com. Arlington Asset Investment Corp. (NYSE:AAIC) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connect

    $AAIC
    $EMBK
    $GRNA
    $REUN
    Real Estate Investment Trusts
    Real Estate
    Computer Software: Prepackaged Software
    Technology

$GRNA
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$GRNA
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$GRNA
SEC Filings

See more

$GRNA
Financials

Live finance-specific insights

See more
  • GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares

    LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. ("Merger Sub") and SW ParentCo, Inc ("Parent"). Following the completion of the Merger, shares of GreenLight common stock are expected to cease trading on the NASDAQ Global Market ("NASDAQ") after market close on July 20, 2023, and will no longer be listed for trading on the NASDAQ. Merger Sub's tender offer (the "Offer") to purchase any and all outstanding shares of GreenLight's common stock (other than shares of GreenLight common stock (

    $GRNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

$GRNA
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more